These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 2837970

  • 1. A brief review of preclinical and clinical studies with LY171883 and some comments on newer cysteinyl leukotriene receptor antagonists.
    Fleisch JH, Cloud ML, Marshall WS.
    Ann N Y Acad Sci; 1988; 524():356-68. PubMed ID: 2837970
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of leukotriene receptor antagonists on isolated human intralobar airways.
    Buckner CK, Saban R, Castleman WL, Will JA.
    Ann N Y Acad Sci; 1988; 524():181-6. PubMed ID: 2837953
    [No Abstract] [Full Text] [Related]

  • 3. Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives.
    Dillard RD, Carr FP, McCullough D, Haisch KD, Rinkema LE, Fleisch JH.
    J Med Chem; 1987 May; 30(5):911-8. PubMed ID: 3033245
    [Abstract] [Full Text] [Related]

  • 4. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647.
    Marshall WS, Sigmund SK, Whitesitt CA, Lifer SL, Roman CR, Rinkema LE, Hahn RA, Fleisch JH.
    Agents Actions; 1989 Jun; 27(3-4):309-12. PubMed ID: 2552762
    [Abstract] [Full Text] [Related]

  • 5. High-affinity leukotriene receptor antagonists. Synthesis and pharmacological characterization of 2-hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl] propanoic acid.
    Gleason JG, Hall RF, Perchonock CD, Erhard KF, Frazee JS, Ku TW, Kondrad K, McCarthy ME, Mong S, Crooke ST.
    J Med Chem; 1987 Jun; 30(6):959-61. PubMed ID: 3035179
    [No Abstract] [Full Text] [Related]

  • 6. Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives.
    Marshall WS, Goodson T, Cullinan GJ, Swanson-Bean D, Haisch KD, Rinkema LE, Fleisch JH.
    J Med Chem; 1987 Apr; 30(4):682-9. PubMed ID: 3031291
    [Abstract] [Full Text] [Related]

  • 7. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
    Snyder DW, Giles RE, Keith RA, Yee YK, Krell RD.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751
    [Abstract] [Full Text] [Related]

  • 8. Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883.
    Rinkema LE, Roman CR, Russell WL, Spaethe SM, Bemis KG, Henry DP, Marshall WS, Fleisch JH.
    J Pharm Pharmacol; 1990 Sep; 42(9):620-5. PubMed ID: 1706765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonists.
    Marshall WS, Whitesitt CA, Goodson T, Roman C, Rinkema L, Fleisch JH.
    Agents Actions; 1987 Aug; 21(3-4):275-7. PubMed ID: 3687580
    [Abstract] [Full Text] [Related]

  • 11. Leukotriene receptor antagonists. 4. Synthesis and leukotriene D4/E4 receptor antagonist activity of 4-(alkyl)acetophenone derivatives.
    Gapinski DM, Roman CR, Rinkema LE, Fleisch JH.
    J Med Chem; 1988 Jan; 31(1):172-5. PubMed ID: 2826785
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and pharmacological characterization of 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid and 5-[2-(8-phenyloctyl)phenyl]-4,6-dithianonanedioic acid: prototypes of a novel class of leukotriene antagonists.
    Perchonock CD, McCarthy ME, Erhard KF, Gleason JG, Wasserman MA, Muccitelli RM, DeVan JF, Tucker SS, Vickery LM, Kirchner T.
    J Med Chem; 1985 Sep; 28(9):1145-7. PubMed ID: 2993610
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist.
    Wasserman MA, Torphy TJ, Hay DW, Muccitelli RM, Tucker SS, Wilson KA, Osborn RR, Vickery-Clark L, Hall RF, Erhard KF.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Sep; 17A():532-5. PubMed ID: 2821765
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations.
    Etemadi AR, Tempel GE, Farah BA, Wise WC, Halushka PV, Cook JA.
    Circ Shock; 1987 Sep; 22(1):55-63. PubMed ID: 3038364
    [Abstract] [Full Text] [Related]

  • 15. Endotoxemia in rats--influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883).
    Bahrami S, Paul E, Redl H, Schlag G, Mihm F.
    Prog Clin Biol Res; 1988 Sep; 272():283-92. PubMed ID: 2839854
    [No Abstract] [Full Text] [Related]

  • 16. Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".
    Folco G, Bolla M, Santinelli E, Bianco S, Sestini P, Mezzetti M, Sala A.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Sep; 23():365-7. PubMed ID: 7732873
    [No Abstract] [Full Text] [Related]

  • 17. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
    Abraham WM, Wanner A, Stevenson JS, Chapman GA.
    Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
    [Abstract] [Full Text] [Related]

  • 18. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
    Mong S, Wu HL, Miller J, Hall RF, Gleason JG, Crooke ST.
    Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
    [Abstract] [Full Text] [Related]

  • 19. Reversal of leukotriene D4- and leukotriene E4-induced airway constriction in the guinea pig.
    Silbaugh SA, Stengel PW, Pechous PA, Marshall WS.
    Am Rev Respir Dis; 1989 Sep; 140(3):610-4. PubMed ID: 2571321
    [Abstract] [Full Text] [Related]

  • 20. Leukotrienes, airway hyperresponsiveness, and asthma.
    O'Byrne PM.
    Ann N Y Acad Sci; 1988 Sep; 524():282-8. PubMed ID: 2837963
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.